Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Gene Polymorphisms as Predictors of Treatment Efficacy and Toxicity in Patients With Indolent Non-Hodgkin Lymphomas Receiving Bendamustine and Rituximab

Hematological Oncology

English

AUTHOR INDEX (By Abstract No.)

Hematological Oncology

English

Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure

Hematological Oncology

English

Issue Information

Hematological Oncology

English

Long-Term Follow-Up of Patients With Non-Hodgkin Primary Diffuse Large B-Cell Lymphoma of the Stomach: Better Outcome After Immunochemotherapy

Hematological Oncology

English

Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Aggressive Natural Killer Cell Leukemia: A Nationwide Multicenter Analysis in Japan

Hematological Oncology

English

Nkp46 Expression Is a Diagnostic and Prognostic Biomarker in Primary Gastrointestinal T-Cell Lymphoproliferations. A Celac Network Study

Hematological Oncology

English

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY

Hematological Oncology

English

Statin Use and Prognosis in 12,865 Non-Hodgkin Lymphoma Patients Treated in the Rituximab-Era

Hematological Oncology

English

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Gene Polymorphisms as Predictors of Treatment Efficacy and Toxicity in Patients With Indolent Non-Hodgkin Lymphomas Receiving Bendamustine and Rituximab

AUTHOR INDEX (By Abstract No.)

Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure

Issue Information

Long-Term Follow-Up of Patients With Non-Hodgkin Primary Diffuse Large B-Cell Lymphoma of the Stomach: Better Outcome After Immunochemotherapy

Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Aggressive Natural Killer Cell Leukemia: A Nationwide Multicenter Analysis in Japan

Nkp46 Expression Is a Diagnostic and Prognostic Biomarker in Primary Gastrointestinal T-Cell Lymphoproliferations. A Celac Network Study

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY

Statin Use and Prognosis in 12,865 Non-Hodgkin Lymphoma Patients Treated in the Rituximab-Era

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY